Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Elekta AB (publ)    EKTA B   SE0000163628

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Stockholm
11/28/2016 11/29/2016 11/30/2016 12/01/2016 12/02/2016 Date
79.45(c) 77.8(c) 76.2(c) 75.2(c) 75.5(c) Last
1 683 948 1 049 041 2 059 491 5 745 033 2 720 631 Volume
+0.89% -2.08% -2.06% -1.31% +0.40% Change
More quotes
Financials ( SEK)
Sales 2017 11 233 M
EBIT 2017 1 417 M
Net income 2017 818 M
Debt 2017 2 132 M
Yield 2017 1,24%
Sales 2018 11 810 M
EBIT 2018 1 767 M
Net income 2018 1 194 M
Debt 2018 1 189 M
Yield 2018 1,68%
P/E ratio 2017 33,01
P/E ratio 2018 23,88
EV / Sales2017 2,67x
EV / Sales2018 2,46x
Capitalization 27 828 M
More Financials
Company
Elekta AB is engaged in the business of human care, which specializes in the treatment of cancers and brain disorders.It provides oncologists, radiation therapists, neurosurgeons, and other medical specialists with the aid of clinical solutions and tools.Elekta was founded by Lars Leksell and... 
More about the company
Surperformance© ratings of Elekta AB (publ)
Trading Rating : Investor Rating :
More Ratings
Latest news on ELEKTA AB (PUBL)
12/01 ELEKTA PUBL : takes orders for two high-field MR linear accelerators
12/01 ELEKTA PUBL : Interim Report May-October 2016/17
11/28 ELEKTA PUBL : Doctors in Japan begin treating patients with Elekta’s Lekse..
11/28 ELEKTA : Doctors in Japan Begin Treating Patients with Elekta’s Leksell Ga..
11/18 ELEKTA : New Standard of Care Offers Lower Toxicity, Shorter Treatment Times and..
11/18 ELEKTA PUBL : New standard of care offers lower toxicity, shorter treatment time..
11/17 ELEKTA PUBL : Patent Issued for Vision System for Radiotherapy Machine Control (..
11/15 ELEKTA PUBL : Conference call regarding Elekta's Interim Report for May-October ..
11/10 ELEKTA PUBL : Patent Application Titled "Target-Specific Dose and Scatter Estima..
11/09 ELEKTA PUBL : Nomination Committee for the 2017 Annual General Meeting
More news
Sector news : Advanced Medical Equipment & Technology - NEC
12/02 Deals scuppered by U.S. regulatory scrutiny
11/29 European spin-offs and carve-outs
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
11/15 Exclusive - EU regulators seen clearing $25 billion Abbott, St Jude deal
11/02DJU.S. HOT STOCKS : Hot Stocks to Watch
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
12/01 Elekta AB reports FQ2 results
10/14 All Eyes On The Finish
09/01 Elekta AB reports FQ1 results
08/31 Accuray Still Not Delivering Acceleration
06/02 Elekta's (EKTAF) CEO Tomas Puusepp on Q4 2016 Results - Earnings Call Transcr..
Advertisement
Chart ELEKTA AB (PUBL)
Duration : Period :
Elekta AB (publ) Technical Analysis Chart | EKTA B | SE0000163628 | 4-Traders
Full-screen chart
Technical analysis trends ELEKTA AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 74,5  SEK
Spread / Average Target -1,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Richard Hausmann President & Chief Executive Officer
Laurent Leksell Chairman
Johan Sedihn Chief Operating Officer & Head-Human Resources
Håkan Bergström Chief Financial Officer
John Lapré Chief Technology Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ELEKTA AB (PUBL)4.30%3 028
THERMO FISHER SCIENTIF..-1.23%56 058
DANAHER CORPORATION9.60%53 482
BOSTON SCIENTIFIC CORP..10.95%27 710
PHILIPS15.05%26 897
INTUITIVE SURGICAL, IN..16.57%24 668
More Results